Schooner Capital LLC is a private investment office based in Boston, Massachusetts, that specializes in growth equity and alternative assets. Established in 1971, the firm focuses on private investments, including private equity and venture capital, across various stages and sectors. It emphasizes investments in private companies within the healthcare, technology, and clean energy sectors, primarily in the United States, while also targeting emerging and frontier markets globally. With a long-term investment approach and no outside limited partners, Schooner Capital seeks to create value through strategic investments in both private and public markets.
Ottometric Inc. is a technology company based in Newton, Massachusetts, that specializes in developing a cloud-based platform for enhancing the safety of autonomous vehicles. Founded in 2018, the company offers an intelligent verification framework that leverages big data, artificial intelligence, sensor fusion, and computer vision to provide insights into events and anomalies in real-world driving scenarios. By focusing on the validation and training of advanced driver assistance systems (ADAS), Ottometric aims to improve the reliability of these systems, addressing the industry's current challenges in delivering effective autonomous capabilities. The platform is designed to automate and streamline the validation process, helping automotive companies reduce development costs while advancing the safety and efficacy of driver assistance features.
Meili
Seed Round in 2024
Meili is a built technology that allows mobility company to interact with travel partners offering a frictionless consumer experience.
Mantle
Series C in 2024
Mantle Inc. is an engineering and manufacturing company based in Montreal, Canada, specializing in advanced metal 3D printing technology. Established in 2017, the company focuses on producing high-resolution parts for various applications, including automotive, aerospace, and consumer product design. Mantle's offerings include a platform that utilizes additive technology, known as TrueShape, which enables the production of finished parts, as well as a set of enterprise blockchain development products through a blockchain as a service model. By providing precision parts, Mantle significantly reduces the time and cost associated with creating production-grade tools, molds, and dies, thereby meeting the needs of tool manufacturers, tool makers, and original equipment manufacturers.
Cartesian Therapeutics
Post in 2024
Cartesian Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in the United States that specializes in developing innovative cell and gene immunotherapies for the treatment of cancer and autoimmune diseases. The company focuses on chimeric antigen receptor therapies to address multiple myeloma and other forms of cancer. Cartesian Therapeutics employs its proprietary ImmTOR immune tolerance platform, which aims to foster antigen-specific immunity while reducing unwanted immune responses. This approach utilizes a manufacturing platform to introduce mRNA molecules into cells, enhancing their functionality without the risk of integration into the cell's genetic material, as mRNA naturally degrades over time.
Brixton Biosciences
Series B in 2024
Brixton Biosciences is a clinical-stage life sciences company focused on developing innovative therapies for chronic and acute pain management. The company aims to address significant unmet needs in this area, which has traditionally relied on systemic medications. Its flagship product, Neural Ice™, is a drug-free injectable treatment designed to induce reversible inhibition of nerves, offering a non-addictive, locally targeted solution. This therapy provides patients with extended pain relief lasting from thirty to sixty days following a single injection, representing a significant advancement over current pain management methods.
SeLux Diagnostics
Venture Round in 2024
SeLux Diagnostics, Inc. is a biotechnology company based in Charlestown, Massachusetts, founded in 2014. It specializes in developing a next-generation phenotyping platform for antibiotic susceptibility testing and diagnostics of infectious diseases. The company utilizes a synthetic amplifier technology that enhances the speed and complexity of antibiotic susceptibility testing, facilitating quicker and more accurate selection of personalized antimicrobial therapies for patients. By streamlining the identification of effective treatments, SeLux Diagnostics aims to improve patient care, reduce hospital stays, and tackle the growing issue of antibiotic resistance by minimizing the reliance on broad-spectrum antibiotics.
Jetcool
Series A in 2023
JETCOOL Technologies specializes in the development of microjet cooling modules aimed at enhancing the performance and longevity of high-power electronics. Founded in 2019 and based in Littleton, Massachusetts, the company leverages technology originally developed at MIT Lincoln Laboratory. By using small jets of fluid integrated into modular cooling components, JETCOOL’s solutions effectively reduce heat and power consumption in electronic devices. This innovation is particularly beneficial for industries such as aerospace, defense, and electronics, where managing heat is crucial for device reliability and efficiency.
Congruity
Venture Round in 2023
Congruity is a comprehensive data management and IT support services provider, enhancing technology investments through improved data quality and cost optimization. The company serves over 1,000 partners worldwide, offering end-user installation, local on-site support, consulting, and full data center hosting capabilities across more than 100 countries. With a network of 12,000 service professionals and a team of experienced engineers, Congruity delivers complete support throughout the entire lifecycle of IT infrastructure, from implementation to disaster recovery. The firm is dedicated to providing on-demand visibility and control while ensuring same-day, on-site support globally. Born from the merger of MSDI and Rockland IT Solutions, Congruity combines over 40 years of industry experience and has successfully managed more than two million IT systems at over 26,000 sites. The company fosters deep relationships with its strategic partners, providing scalable and expert services designed to meet the evolving needs of technology providers.
Censinet
Venture Round in 2023
Censinet, Inc. is a healthcare-focused SaaS company that offers a cloud-based platform for managing third-party risk assessments. Founded in 2017 and based in Winchester, Massachusetts, Censinet connects healthcare providers with their vendors, streamlining the process of assessing and managing risks in real time. The platform eliminates the need for inefficient spreadsheets and manual workflows by automating risk assessments and providing continuous insights into vendor profiles. This approach enables healthcare organizations to identify and address potential threats within their vendor ecosystem effectively, enhancing overall cybersecurity and operational efficiency.
Breezeway
Venture Round in 2022
Breezeway Homes, Inc. is a Boston-based company that specializes in developing intelligent property maintenance and home management software. Founded in 2015, Breezeway offers a comprehensive platform that facilitates the coordination, communication, and verification of property care tasks. Its software is designed to enhance operational efficiency for various sectors, including vacation rentals, residential rentals, corporate housing, hotels, and cleaning services. The platform enables property managers and owners to automate tasks, conduct inspections, monitor property readiness, and communicate seamlessly with both internal staff and external service partners. By leveraging advanced technology for task management and scheduling, Breezeway helps businesses maintain their properties effectively while improving client satisfaction.
Zippity
Seed Round in 2022
Zippity LLC, founded in 2015 and based in Boston, Massachusetts, specializes in onsite car maintenance and repair services. The company operates an innovative platform that allows customers to schedule various automotive services, such as tire changes, detailing, brake work, and more, at their home or workplace. Zippity provides a unique B2B operating system tailored specifically for the mobile automotive industry, enhancing the customer experience across multiple service segments. By offering the convenience of mobile garage services, Zippity aims to alleviate the difficulties associated with car ownership, enabling mechanics to perform comprehensive maintenance directly at the vehicle's location.
SeLux Diagnostics
Series C in 2022
SeLux Diagnostics, Inc. is a biotechnology company based in Charlestown, Massachusetts, founded in 2014. It specializes in developing a next-generation phenotyping platform for antibiotic susceptibility testing and diagnostics of infectious diseases. The company utilizes a synthetic amplifier technology that enhances the speed and complexity of antibiotic susceptibility testing, facilitating quicker and more accurate selection of personalized antimicrobial therapies for patients. By streamlining the identification of effective treatments, SeLux Diagnostics aims to improve patient care, reduce hospital stays, and tackle the growing issue of antibiotic resistance by minimizing the reliance on broad-spectrum antibiotics.
Amplified Industries
Seed Round in 2022
Amplified Industries specializes in providing an Internet of Things (IoT) solution aimed at enhancing the efficiency of artificial lift systems in oil fields. The company has developed an industrial automation platform that enables real-time monitoring, control, and optimization of these systems and their related assets. By focusing on reducing lifting costs and minimizing methane emissions, Amplified Industries helps industrial businesses maximize output, extend equipment lifespan, and lessen their environmental impact. Their holistic approach emphasizes efficacy and usability, positioning them as a key player in the intersection of energy production and environmental sustainability.
Commonwealth Fusion Systems
Series B in 2021
Commonwealth Fusion Systems LLC is a research and development company focused on advancing fusion energy technology to provide an inexhaustible power source. Established in 2017 and based in Cambridge, Massachusetts, the company utilizes rare-earth barium copper oxide superconductor technology to create fusion energy systems. Commonwealth Fusion Systems was spun out of the Massachusetts Institute of Technology (MIT) and collaborates with MIT’s Plasma Science and Fusion Center to leverage decades of government-funded fusion research. By integrating established physics with innovative magnet technology, the company aims to accelerate the commercialization of fusion energy, positioning itself as a key player in the transition to clean and renewable energy sources while addressing climate change challenges.
Zippity
Seed Round in 2021
Zippity LLC, founded in 2015 and based in Boston, Massachusetts, specializes in onsite car maintenance and repair services. The company operates an innovative platform that allows customers to schedule various automotive services, such as tire changes, detailing, brake work, and more, at their home or workplace. Zippity provides a unique B2B operating system tailored specifically for the mobile automotive industry, enhancing the customer experience across multiple service segments. By offering the convenience of mobile garage services, Zippity aims to alleviate the difficulties associated with car ownership, enabling mechanics to perform comprehensive maintenance directly at the vehicle's location.
MarginEdge
Series B in 2021
MarginEdge Co. is a technology company that specializes in developing food and beverage tracking and analytics software specifically for the restaurant industry. Founded in 2015 and based in Falls Church, Virginia, the company offers a comprehensive software solution that facilitates invoice management, recipe and product pricing, and food cost optimization. MarginEdge's software automates critical processes and integrates various systems to streamline essential activities such as inventory management, cost tracking, ordering, and recipe management. By automating data entry for invoices and providing real-time insights into kitchen operations, MarginEdge helps restaurants reduce food costs, alleviate invoice-related challenges, and enhance overall operational efficiency.
Jetcool
Venture Round in 2021
JETCOOL Technologies specializes in the development of microjet cooling modules aimed at enhancing the performance and longevity of high-power electronics. Founded in 2019 and based in Littleton, Massachusetts, the company leverages technology originally developed at MIT Lincoln Laboratory. By using small jets of fluid integrated into modular cooling components, JETCOOL’s solutions effectively reduce heat and power consumption in electronic devices. This innovation is particularly beneficial for industries such as aerospace, defense, and electronics, where managing heat is crucial for device reliability and efficiency.
Wren Therapeutics
Venture Round in 2021
Wren Therapeutics Limited is a biopharmaceutical company based in Cambridge, United Kingdom, that specializes in the development of small molecule therapeutics targeting protein misfolding diseases. Founded in 2016, the company focuses on conditions such as Alzheimer's and Parkinson's diseases, type 2 diabetes, and various rare forms of amyloidosis. Wren's proprietary technology platform is grounded in a deep understanding of the origins of these diseases, drawing on extensive scientific research conducted at the University of Cambridge and Lund University. Through this innovative platform, Wren aims to advance drug discovery and development for a range of serious neurological and rare disorders.
Cullinan Therapeutics
Series C in 2020
Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics intended to end a drug program quickly if the early research suggests it won't work. The company's therapeutics are developed via assets sourced internally through dry lab or externally through business, academic and pharma collaborations, enabling researchers to get a highly diversified portfolio of oncology therapeutics with a unique, cost-efficient business model.
Zippity
Venture Round in 2020
Zippity LLC, founded in 2015 and based in Boston, Massachusetts, specializes in onsite car maintenance and repair services. The company operates an innovative platform that allows customers to schedule various automotive services, such as tire changes, detailing, brake work, and more, at their home or workplace. Zippity provides a unique B2B operating system tailored specifically for the mobile automotive industry, enhancing the customer experience across multiple service segments. By offering the convenience of mobile garage services, Zippity aims to alleviate the difficulties associated with car ownership, enabling mechanics to perform comprehensive maintenance directly at the vehicle's location.
Breezeway
Series A in 2020
Breezeway Homes, Inc. is a Boston-based company that specializes in developing intelligent property maintenance and home management software. Founded in 2015, Breezeway offers a comprehensive platform that facilitates the coordination, communication, and verification of property care tasks. Its software is designed to enhance operational efficiency for various sectors, including vacation rentals, residential rentals, corporate housing, hotels, and cleaning services. The platform enables property managers and owners to automate tasks, conduct inspections, monitor property readiness, and communicate seamlessly with both internal staff and external service partners. By leveraging advanced technology for task management and scheduling, Breezeway helps businesses maintain their properties effectively while improving client satisfaction.
Commonwealth Fusion Systems
Series A in 2020
Commonwealth Fusion Systems LLC is a research and development company focused on advancing fusion energy technology to provide an inexhaustible power source. Established in 2017 and based in Cambridge, Massachusetts, the company utilizes rare-earth barium copper oxide superconductor technology to create fusion energy systems. Commonwealth Fusion Systems was spun out of the Massachusetts Institute of Technology (MIT) and collaborates with MIT’s Plasma Science and Fusion Center to leverage decades of government-funded fusion research. By integrating established physics with innovative magnet technology, the company aims to accelerate the commercialization of fusion energy, positioning itself as a key player in the transition to clean and renewable energy sources while addressing climate change challenges.
Zippity
Seed Round in 2019
Zippity LLC, founded in 2015 and based in Boston, Massachusetts, specializes in onsite car maintenance and repair services. The company operates an innovative platform that allows customers to schedule various automotive services, such as tire changes, detailing, brake work, and more, at their home or workplace. Zippity provides a unique B2B operating system tailored specifically for the mobile automotive industry, enhancing the customer experience across multiple service segments. By offering the convenience of mobile garage services, Zippity aims to alleviate the difficulties associated with car ownership, enabling mechanics to perform comprehensive maintenance directly at the vehicle's location.
Commonwealth Fusion Systems
Series A in 2019
Commonwealth Fusion Systems LLC is a research and development company focused on advancing fusion energy technology to provide an inexhaustible power source. Established in 2017 and based in Cambridge, Massachusetts, the company utilizes rare-earth barium copper oxide superconductor technology to create fusion energy systems. Commonwealth Fusion Systems was spun out of the Massachusetts Institute of Technology (MIT) and collaborates with MIT’s Plasma Science and Fusion Center to leverage decades of government-funded fusion research. By integrating established physics with innovative magnet technology, the company aims to accelerate the commercialization of fusion energy, positioning itself as a key player in the transition to clean and renewable energy sources while addressing climate change challenges.
Censinet
Series A in 2019
Censinet, Inc. is a healthcare-focused SaaS company that offers a cloud-based platform for managing third-party risk assessments. Founded in 2017 and based in Winchester, Massachusetts, Censinet connects healthcare providers with their vendors, streamlining the process of assessing and managing risks in real time. The platform eliminates the need for inefficient spreadsheets and manual workflows by automating risk assessments and providing continuous insights into vendor profiles. This approach enables healthcare organizations to identify and address potential threats within their vendor ecosystem effectively, enhancing overall cybersecurity and operational efficiency.
SeLux Diagnostics
Series B in 2018
SeLux Diagnostics, Inc. is a biotechnology company based in Charlestown, Massachusetts, founded in 2014. It specializes in developing a next-generation phenotyping platform for antibiotic susceptibility testing and diagnostics of infectious diseases. The company utilizes a synthetic amplifier technology that enhances the speed and complexity of antibiotic susceptibility testing, facilitating quicker and more accurate selection of personalized antimicrobial therapies for patients. By streamlining the identification of effective treatments, SeLux Diagnostics aims to improve patient care, reduce hospital stays, and tackle the growing issue of antibiotic resistance by minimizing the reliance on broad-spectrum antibiotics.
Remedy Plan Therapeutics
Venture Round in 2018
Remedy Plan Therapeutics is a pre-clinical-stage biopharmaceutical company focused on developing small molecule therapeutics aimed at halting tumor growth and disrupting cancer stem cells, which are responsible for metastasis and chemotherapy resistance. The company employs a proprietary drug screening platform that identifies candidates capable of differentiating cancer stem cells and inhibiting tumor formation. In its initial screening, Remedy Plan evaluated 40,000 drug components, leading to the optimization of a lead candidate that is currently undergoing mechanism of action studies in preparation for Phase I clinical trials. Additionally, a second screening of over 100,000 drug components has been completed, positioning the company to potentially advance at least two drug candidates into clinical development. Through its innovative approach, Remedy Plan aims to address various cancers, including solid tumors and hematologic malignancies, while also exploring applications in obesity and autoimmune disorders.
SRS Medical Systems
Venture Round in 2018
SRS Medical Systems, Inc. is a medical device company specializing in solutions for patients with male lower urinary tract symptoms. Founded in 1991 and headquartered in North Billerica, Massachusetts, the company develops a range of proprietary devices aimed at diagnosing and treating voiding disorders. Its notable products include the UroCuff Test, which assesses bladder function during urination; The Spanner Stent, a temporary urethral stent that aids urine flow; and The VP Test, designed for evaluating bladder function in catheterized patients. Additionally, SRS Medical offers essential diagnostic tools such as the EasyPro 4, a 12-channel urodynamics system, and EasyFlo, a stand-alone uroflow system. With facilities in both Redmond, Washington, and Billerica, Massachusetts, SRS Medical is committed to improving patient awareness and treatment of urinary conditions.
Spotted
Series A in 2018
Spotted helps brands and agencies make smarter, safer celebrity partnership decisions. Spotted is the authority in celebrity data and research offering celebrity-brand fit, celebrity risk assessment, celebrity personality assessment, and predictive analytics.
SRS Medical Systems
Venture Round in 2017
SRS Medical Systems, Inc. is a medical device company specializing in solutions for patients with male lower urinary tract symptoms. Founded in 1991 and headquartered in North Billerica, Massachusetts, the company develops a range of proprietary devices aimed at diagnosing and treating voiding disorders. Its notable products include the UroCuff Test, which assesses bladder function during urination; The Spanner Stent, a temporary urethral stent that aids urine flow; and The VP Test, designed for evaluating bladder function in catheterized patients. Additionally, SRS Medical offers essential diagnostic tools such as the EasyPro 4, a 12-channel urodynamics system, and EasyFlo, a stand-alone uroflow system. With facilities in both Redmond, Washington, and Billerica, Massachusetts, SRS Medical is committed to improving patient awareness and treatment of urinary conditions.
Censinet
Seed Round in 2017
Censinet, Inc. is a healthcare-focused SaaS company that offers a cloud-based platform for managing third-party risk assessments. Founded in 2017 and based in Winchester, Massachusetts, Censinet connects healthcare providers with their vendors, streamlining the process of assessing and managing risks in real time. The platform eliminates the need for inefficient spreadsheets and manual workflows by automating risk assessments and providing continuous insights into vendor profiles. This approach enables healthcare organizations to identify and address potential threats within their vendor ecosystem effectively, enhancing overall cybersecurity and operational efficiency.
eXIthera Pharmaceuticals
Venture Round in 2017
eXIthera Pharmaceuticals, Inc. is an early-stage biotechnology company based in Westborough, Massachusetts, established in 2012. It specializes in developing small molecule pharmaceuticals that target Factor XIa, a key enzyme in the blood coagulation pathway. The company's innovative approach aims to create drugs for stroke prevention and thrombosis management, addressing conditions such as venous thromboembolism, deep vein thrombosis, stroke, and heart attack. eXIthera's inhibitors are designed to prevent thrombosis while minimizing the risk of bleeding side effects and eliminating the need for reversal agents, thereby offering a safer alternative for patients at risk of serious cardiovascular events.
Millstone Medical
Private Equity Round in 2017
Millstone provider of outsourced quality-critical services for medical manufacturers. The Company is strategically positioned to benefit from several strong secular trends, including increased demand for outsourced post-manufacturing services and significant growth in robotic-assisted surgery.
MediaSilo
Venture Round in 2017
When video workflows operate like a well-oiled machine, teams can stop worrying about security and focus on producing better content, faster and more efficiently. MediaSilo is a video management platform for distributed media production teams that need to manage, share and approve content safely and easily. The Boston, MA-based company works with media companies, advertising agencies and content creators to provide lightweight SaaS software that sits in the middle of video lifecycles, working with existing tools and workflows to keep teams connected, assets secure and stories beautifully and seamlessly presented. With 550+ customers, 100k+ monthly users and 10M+ assets managed, MediaSilo continues to innovate and provide solutions that span media, entertainment and enterprise video, with a focus on security. Most recently, MediaSilo launched SafeStream, an on-demand watermarking technology that acts as a visual deterrant to piracy. Each watermarked video is created in real-time and is personalized to the person requesting or viewing the asset. Because the customized watermark is inserted in near real-time (less than a 20-second delay) – even for a 90-minute video – the speed and cost-effectiveness of SafeStream is unheard of the industry, and is not interruptive to the viewing experience. The content owner remains in complete control of where and how the watermark appears on the video. It can be incorporated directly into workflows so it can be easily used to protect dailies and rough cuts in addition to finished content.
East Point Capital
Venture Round in 2017
East Point Capital is an investment and real estate development company. They hold and manage securities for investment purposes, but they offer investors a variety of funds and investment services, which include portfolio management, recordkeeping, custodial, legal, accounting, and tax management services.
F&B Asia Ventures
Venture Round in 2017
F&B Asia Ventures is a holding company focused on creating and enhancing quality dining concepts in the Southeast Asia region. The company operates within the food services and hospitality sectors, aiming to develop robust food and beverage brands that span various geographies, formats, and cuisines. By providing growth opportunities for food and beverage companies, F&B Asia Ventures plays a significant role in shaping the dining landscape in Southeast Asia.
4G Clinical
Series A in 2016
4G Clinical, Inc. specializes in providing randomization and trial supply management services for pharmaceutical companies and clinical research organizations globally. Founded in 2015 and headquartered in Wellesley, Massachusetts, the company supports phase 2 and phase 3 clinical trials through its innovative Prancer RTSM software. This cloud-based platform employs natural language processing to enhance operational efficiencies, optimize clinical supply forecasting, and streamline the assignment of patients to treatment groups. Additionally, 4G Clinical offers a Direct-to-Patient clinical trial platform, enabling the direct shipment of medications from various sources to patients' homes. With offices in Amsterdam and Tokyo, the company combines global expertise with advisory services to meet the evolving needs of the life sciences industry.
eXIthera Pharmaceuticals
Series B in 2016
eXIthera Pharmaceuticals, Inc. is an early-stage biotechnology company based in Westborough, Massachusetts, established in 2012. It specializes in developing small molecule pharmaceuticals that target Factor XIa, a key enzyme in the blood coagulation pathway. The company's innovative approach aims to create drugs for stroke prevention and thrombosis management, addressing conditions such as venous thromboembolism, deep vein thrombosis, stroke, and heart attack. eXIthera's inhibitors are designed to prevent thrombosis while minimizing the risk of bleeding side effects and eliminating the need for reversal agents, thereby offering a safer alternative for patients at risk of serious cardiovascular events.
Spotted
Seed Round in 2016
Spotted helps brands and agencies make smarter, safer celebrity partnership decisions. Spotted is the authority in celebrity data and research offering celebrity-brand fit, celebrity risk assessment, celebrity personality assessment, and predictive analytics.
Maxwell Health
Series C in 2016
Maxwell Health offers a software-as-a-service platform that simplifies employee benefits and human resources for small to mid-sized employers. Founded in 2012 and headquartered in New York, with an additional office in Cambridge, Massachusetts, the company provides a comprehensive online service that includes information on various insurance products such as medical, dental, vision, and life insurance, as well as tools for benefits administration, payroll, and COBRA management. The platform features an intuitive marketplace that streamlines the process of purchasing benefits for employees and includes a mobile application for easy access. Maxwell Health aims to enhance the experience of insurance, financial, and wellness benefits for American families, leveraging its technology through partnerships with benefits advisors and insurance companies. In June 2018, Maxwell Health became a subsidiary of Sun Life Financial United States.
Cyft
Seed Round in 2016
Cyft, Inc. is a Boston-based company that specializes in developing a cloud-based predictive analytics platform aimed at enhancing healthcare management. Founded in 2015, Cyft partners with various healthcare organizations, including providers, health plans, and life sciences companies, to optimize care management for chronic and complex conditions, as well as behavioral health and dual-eligible populations. The platform utilizes advanced machine learning and natural language processing technologies to analyze a wide array of healthcare data, from claims to case management notes. By leveraging this data, Cyft helps Medicaid plans implement tailored interventions that improve both member health outcomes and financial performance. The company combines technological solutions with hands-on support from healthcare experts, enabling clients to integrate effective practices into their existing workflows. This approach has successfully generated over $100 million in cost savings and new revenue for more than 20 healthcare plans, while also enhancing member retention and satisfaction.
4G Clinical
Series A in 2016
4G Clinical, Inc. specializes in providing randomization and trial supply management services for pharmaceutical companies and clinical research organizations globally. Founded in 2015 and headquartered in Wellesley, Massachusetts, the company supports phase 2 and phase 3 clinical trials through its innovative Prancer RTSM software. This cloud-based platform employs natural language processing to enhance operational efficiencies, optimize clinical supply forecasting, and streamline the assignment of patients to treatment groups. Additionally, 4G Clinical offers a Direct-to-Patient clinical trial platform, enabling the direct shipment of medications from various sources to patients' homes. With offices in Amsterdam and Tokyo, the company combines global expertise with advisory services to meet the evolving needs of the life sciences industry.
Cartesian Therapeutics
Venture Round in 2016
Cartesian Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in the United States that specializes in developing innovative cell and gene immunotherapies for the treatment of cancer and autoimmune diseases. The company focuses on chimeric antigen receptor therapies to address multiple myeloma and other forms of cancer. Cartesian Therapeutics employs its proprietary ImmTOR immune tolerance platform, which aims to foster antigen-specific immunity while reducing unwanted immune responses. This approach utilizes a manufacturing platform to introduce mRNA molecules into cells, enhancing their functionality without the risk of integration into the cell's genetic material, as mRNA naturally degrades over time.
Zixi
Venture Round in 2015
Zixi, LLC specializes in providing innovative solutions for the delivery of broadcast-quality HD video over the Internet, Wi-Fi, and mobile networks. Founded in 2006 and headquartered in Waltham, Massachusetts, the company offers the Zixi Video Transport Platform, which serves broadcasters, enterprises, and over-the-top video providers globally. This platform facilitates the seamless transmission of live and on-demand video content while ensuring high quality and efficiency. Zixi's offerings include automated content quality analytics, ZEN Management for channel orchestration, and various applications such as news gathering, sports broadcasting, and virtual events. Additionally, Zixi provides cloud services for live events and video distribution tailored for mobile users and enterprises. Through its technology, Zixi transforms unmanaged connections into reliable networks for video delivery, enabling users to adopt more dynamic and cost-effective broadcasting models. The company maintains a strategic partnership with PeerTV Ltd., enhancing its market reach and service capabilities.
Emerald Cloud Lab
Venture Round in 2015
Emerald Cloud Lab, Inc. is a biotechnology company based in South San Francisco, California, that develops an innovative life sciences laboratory designed to streamline and enhance scientific research. Founded in 2010 by two scientists, the company aims to address the challenges of rising research and development costs in the pharmaceutical industry by automating and optimizing laboratory workflows. The Emerald Cloud Laboratory provides a comprehensive facility that manages various aspects of laboratory operations, including method design, materials logistics, sample preparation, instrument operation, data acquisition, analysis, and waste disposal. This approach allows researchers to focus on designing experiments and analyzing results rather than on routine tasks, thereby accelerating the pace of innovation in life sciences. Emerald's commitment to improving laboratory efficiency reflects a vision of driving significant advancements in research and development akin to the technological shifts seen in the semiconductor industry.
Fashion Project
Series A in 2015
Fashion Project, Inc. is an online platform that allows members to donate clothing and shop for causes they are passionate about. The company offers a range of items, including apparel, shoes, and accessories, with many products donated by celebrities and philanthropists. Members can purchase various clothing types such as dresses, denims, jackets, and footwear, while the majority of the proceeds from sales are directed to charitable organizations. Established in 2011 and headquartered in Boston, Massachusetts, Fashion Project also provides opportunities for clients to initiate fundraising programs, enhancing its commitment to philanthropy. The company was previously known as Swapfish, Inc. before rebranding in June 2012.
Maxwell Health
Series B in 2014
Maxwell Health offers a software-as-a-service platform that simplifies employee benefits and human resources for small to mid-sized employers. Founded in 2012 and headquartered in New York, with an additional office in Cambridge, Massachusetts, the company provides a comprehensive online service that includes information on various insurance products such as medical, dental, vision, and life insurance, as well as tools for benefits administration, payroll, and COBRA management. The platform features an intuitive marketplace that streamlines the process of purchasing benefits for employees and includes a mobile application for easy access. Maxwell Health aims to enhance the experience of insurance, financial, and wellness benefits for American families, leveraging its technology through partnerships with benefits advisors and insurance companies. In June 2018, Maxwell Health became a subsidiary of Sun Life Financial United States.
eXIthera Pharmaceuticals
Venture Round in 2014
eXIthera Pharmaceuticals, Inc. is an early-stage biotechnology company based in Westborough, Massachusetts, established in 2012. It specializes in developing small molecule pharmaceuticals that target Factor XIa, a key enzyme in the blood coagulation pathway. The company's innovative approach aims to create drugs for stroke prevention and thrombosis management, addressing conditions such as venous thromboembolism, deep vein thrombosis, stroke, and heart attack. eXIthera's inhibitors are designed to prevent thrombosis while minimizing the risk of bleeding side effects and eliminating the need for reversal agents, thereby offering a safer alternative for patients at risk of serious cardiovascular events.
RailComm
Series B in 2014
RailComm LLC specializes in the design and implementation of rail automation systems and software tailored for the freight, transit, and industrial sectors. The company offers a range of solutions, including yard automation with automated switching, wireless remote control, and dynamic yard mapping. Additionally, it provides mainline automation services such as centralized traffic control systems and server-based software platforms. RailComm's offerings also encompass supervisory control and data acquisition systems that facilitate train identification, intrusion detection, and various monitoring functionalities. Established in 1999 and headquartered in Fairport, New York, RailComm serves a diverse clientele, including class 1 freight, shortline, regional, transit, intermodal, and industrial rail operators across North America, Latin America, and Africa. The company emphasizes collaboration with clients to deliver flexible and scalable automation solutions that yield immediate returns on investment.
Topokine Therapeutics
Venture Round in 2014
Allergan is a $23 billion diversified global pharmaceutical company and a leader in a new industry model - Growth Pharma. The company is anchored by strong and sustainable brand franchises, a leading global generics business, a premier pipeline, highly efficient operations and an experienced management team creating an unrivaled foundation for long-term growth. Driving continued innovation and growth is the combined company’s strong commitment to R&D, with an investment of ~$1.7 billion in 2015, focused on strategic development of innovative and durable value-enhancing products within brands, generics, biologics and OTC portfolios. The Company’s Generics portfolio features more than 1,000 generics, branded generics, established brands and OTC products. The Company is the third largest generic manufacturer in the U.S. and holds a top 5 leadership position in nearly 20 International markets. Allergan has global headquarters in Dublin, Ireland and U.S. Administrative Headquarters in Parsippany, New Jersey, USA.
Emerald Cloud Lab
Venture Round in 2014
Emerald Cloud Lab, Inc. is a biotechnology company based in South San Francisco, California, that develops an innovative life sciences laboratory designed to streamline and enhance scientific research. Founded in 2010 by two scientists, the company aims to address the challenges of rising research and development costs in the pharmaceutical industry by automating and optimizing laboratory workflows. The Emerald Cloud Laboratory provides a comprehensive facility that manages various aspects of laboratory operations, including method design, materials logistics, sample preparation, instrument operation, data acquisition, analysis, and waste disposal. This approach allows researchers to focus on designing experiments and analyzing results rather than on routine tasks, thereby accelerating the pace of innovation in life sciences. Emerald's commitment to improving laboratory efficiency reflects a vision of driving significant advancements in research and development akin to the technological shifts seen in the semiconductor industry.
Seventh Generation
Venture Round in 2013
Seventh Generation, Inc. is a manufacturer of plant-based household products based in Burlington, Vermont. Founded in 1988, the company offers a diverse range of items including laundry detergents, cleaners, dishwashing liquids, personal care products, and baby care essentials. Committed to environmental sustainability, Seventh Generation emphasizes the use of natural ingredients and ethical practices, ensuring that its products are safe, effective, and non-toxic. The company prioritizes the health of consumers, their families, and the environment, utilizing recycled materials in its packaging and avoiding animal testing. As a subsidiary of Unilever N.V., Seventh Generation distributes its products through a network of retailers, aiming to provide mindful solutions that support both individual well-being and broader ecological goals.
Mimetogen Pharmaceuticals
Venture Round in 2013
Mimetogen Pharmaceuticals Inc. is a clinical-stage biotechnology company based in Montreal, Canada, specializing in the development of peptidomimetics aimed at addressing ophthalmic diseases with significant unmet medical needs. The company is focused on the treatment of conditions such as dry eye syndrome, glaucoma, and degenerative retinal diseases, including retinitis pigmentosa and dry age-related macular degeneration. Mimetogen's lead product, MIM-D3, is specifically designed for managing dry eye syndrome. Established in 2004, Mimetogen Pharmaceuticals is committed to advancing therapeutic options for patients suffering from these eye conditions.
CustomMade
Series B in 2013
CustomMade is an online marketplace that links buyers seeking unique, custom creations with skilled makers across various trades. Established in 1996, the platform was designed to help people find one-of-a-kind gifts and products that are often unavailable through traditional retail channels. Since its acquisition in 2009, CustomMade has expanded significantly, growing from a small community of 350 carpenters to a network of over 12,000 makers. The platform emphasizes a combination of personalized customer service and expert craftsmanship, making it easier for consumers to access customized goods at affordable prices.
Fashion Project
Seed Round in 2013
Fashion Project, Inc. is an online platform that allows members to donate clothing and shop for causes they are passionate about. The company offers a range of items, including apparel, shoes, and accessories, with many products donated by celebrities and philanthropists. Members can purchase various clothing types such as dresses, denims, jackets, and footwear, while the majority of the proceeds from sales are directed to charitable organizations. Established in 2011 and headquartered in Boston, Massachusetts, Fashion Project also provides opportunities for clients to initiate fundraising programs, enhancing its commitment to philanthropy. The company was previously known as Swapfish, Inc. before rebranding in June 2012.
MediaSilo
Series A in 2013
When video workflows operate like a well-oiled machine, teams can stop worrying about security and focus on producing better content, faster and more efficiently. MediaSilo is a video management platform for distributed media production teams that need to manage, share and approve content safely and easily. The Boston, MA-based company works with media companies, advertising agencies and content creators to provide lightweight SaaS software that sits in the middle of video lifecycles, working with existing tools and workflows to keep teams connected, assets secure and stories beautifully and seamlessly presented. With 550+ customers, 100k+ monthly users and 10M+ assets managed, MediaSilo continues to innovate and provide solutions that span media, entertainment and enterprise video, with a focus on security. Most recently, MediaSilo launched SafeStream, an on-demand watermarking technology that acts as a visual deterrant to piracy. Each watermarked video is created in real-time and is personalized to the person requesting or viewing the asset. Because the customized watermark is inserted in near real-time (less than a 20-second delay) – even for a 90-minute video – the speed and cost-effectiveness of SafeStream is unheard of the industry, and is not interruptive to the viewing experience. The content owner remains in complete control of where and how the watermark appears on the video. It can be incorporated directly into workflows so it can be easily used to protect dailies and rough cuts in addition to finished content.
CustomMade
Series B in 2012
CustomMade is an online marketplace that links buyers seeking unique, custom creations with skilled makers across various trades. Established in 1996, the platform was designed to help people find one-of-a-kind gifts and products that are often unavailable through traditional retail channels. Since its acquisition in 2009, CustomMade has expanded significantly, growing from a small community of 350 carpenters to a network of over 12,000 makers. The platform emphasizes a combination of personalized customer service and expert craftsmanship, making it easier for consumers to access customized goods at affordable prices.
SHIFT
Venture Round in 2012
SHIFT is a provider of cloud-based media collaboration and digital asset management solutions, specializing in tools specifically designed for the media and entertainment industry. Founded in 2017 and headquartered in Boston, Massachusetts, the company offers several products that enhance the creation, sharing, and storage of media content. These include Wiredrive for organizing and presenting presentations, Mediasilo for video sharing, Safestream for video protection, and Screeners.com for secure video sharing and collaboration. SHIFT is recognized as a pioneer in developing media-specific collaboration software tailored for enterprises, brands, and agencies in the sector.
Nanoscale Powders
Venture Round in 2012
Nanoscale Powders LLC is a manufacturer specializing in metal compositions and powders, including titanium metals and alloys, intermetallic powders, and silicon alloy powders designed for lithium-ion anode development. The company produces a variety of refractory metals and alloys, such as hafnium bars and nickel-based powders. Its products cater to diverse industries, including aerospace, medical, energy, and nuclear applications. Nanoscale Powders, formerly known as Boston Electronic Materials, was founded in 2008 and is headquartered in Boston, Massachusetts, with manufacturing facilities located in Fitchburg, Massachusetts, and York, Pennsylvania. The company employs a patented metallothermic reduction process to create low-oxygen metals, enhancing their usability in cold spray deposition and metal injection molding, thereby supporting advancements in the aerospace and industrial sectors.
Best Doctors
Venture Round in 2011
Best Doctors offers a unique employee health benefit designed to enhance the quality and cost-effectiveness of healthcare. The company provides an inter-consultation service that connects members with leading medical experts to ensure accurate diagnoses and appropriate treatment options. By facilitating access to top-tier medical knowledge, Best Doctors empowers individuals facing critical health decisions, allowing them to verify their diagnoses and treatment plans. This service not only aids in making informed healthcare choices but also aims to match patients with specialists who can thoroughly review their medical cases and provide clear, comprehensible reports. Through its innovative approach, Best Doctors seeks to improve overall patient outcomes and instill confidence in the medical decision-making process.
Zixi
Venture Round in 2011
Zixi, LLC specializes in providing innovative solutions for the delivery of broadcast-quality HD video over the Internet, Wi-Fi, and mobile networks. Founded in 2006 and headquartered in Waltham, Massachusetts, the company offers the Zixi Video Transport Platform, which serves broadcasters, enterprises, and over-the-top video providers globally. This platform facilitates the seamless transmission of live and on-demand video content while ensuring high quality and efficiency. Zixi's offerings include automated content quality analytics, ZEN Management for channel orchestration, and various applications such as news gathering, sports broadcasting, and virtual events. Additionally, Zixi provides cloud services for live events and video distribution tailored for mobile users and enterprises. Through its technology, Zixi transforms unmanaged connections into reliable networks for video delivery, enabling users to adopt more dynamic and cost-effective broadcasting models. The company maintains a strategic partnership with PeerTV Ltd., enhancing its market reach and service capabilities.
IndoStar Capital Finance
Venture Round in 2011
IndoStar Capital Finance is a Non-Banking Financial Company (NBFC) based in Mumbai, India, established in 2011. The company specializes in providing structured-term financing solutions tailored to meet the specific needs of corporations and small and medium enterprises (SMEs). Its offerings include vehicle financing for commercial vehicles, farm equipment, and personal vehicles, as well as home finance and loans against property. IndoStar also engages in acquisition funding, promoter funding for equity buybacks, family settlements, and asset financing. The firm serves a diverse range of sectors, including real estate, steel, cement, media and entertainment, dairy, financial services, and pharmaceuticals, aiming to support projects across various industries.
SRS Medical Systems
Venture Round in 2010
SRS Medical Systems, Inc. is a medical device company specializing in solutions for patients with male lower urinary tract symptoms. Founded in 1991 and headquartered in North Billerica, Massachusetts, the company develops a range of proprietary devices aimed at diagnosing and treating voiding disorders. Its notable products include the UroCuff Test, which assesses bladder function during urination; The Spanner Stent, a temporary urethral stent that aids urine flow; and The VP Test, designed for evaluating bladder function in catheterized patients. Additionally, SRS Medical offers essential diagnostic tools such as the EasyPro 4, a 12-channel urodynamics system, and EasyFlo, a stand-alone uroflow system. With facilities in both Redmond, Washington, and Billerica, Massachusetts, SRS Medical is committed to improving patient awareness and treatment of urinary conditions.
Seventh Generation
Venture Round in 2010
Seventh Generation, Inc. is a manufacturer of plant-based household products based in Burlington, Vermont. Founded in 1988, the company offers a diverse range of items including laundry detergents, cleaners, dishwashing liquids, personal care products, and baby care essentials. Committed to environmental sustainability, Seventh Generation emphasizes the use of natural ingredients and ethical practices, ensuring that its products are safe, effective, and non-toxic. The company prioritizes the health of consumers, their families, and the environment, utilizing recycled materials in its packaging and avoiding animal testing. As a subsidiary of Unilever N.V., Seventh Generation distributes its products through a network of retailers, aiming to provide mindful solutions that support both individual well-being and broader ecological goals.
StyleFeeder
Series A in 2008
StyleFeeder is a social shopping service designed to enhance the online shopping experience. It allows users to browse the internet and compile items such as clothing and gadgets into a personalized StyleFeed, which can be shared with friends. The platform employs a recommendation algorithm that analyzes users' selections to provide tailored shopping suggestions and improve search functionality. Additionally, StyleFeeder offers widgets that enable users to display their StyleFeed on various social networks and personal websites. The service includes social networking features, allowing users with similar tastes, referred to as StyleTwins, to connect and interact. Acquired by Time Inc. in 2010, StyleFeeder operates in a competitive landscape that includes other social shopping platforms.
StyleFeeder
Seed Round in 2007
StyleFeeder is a social shopping service designed to enhance the online shopping experience. It allows users to browse the internet and compile items such as clothing and gadgets into a personalized StyleFeed, which can be shared with friends. The platform employs a recommendation algorithm that analyzes users' selections to provide tailored shopping suggestions and improve search functionality. Additionally, StyleFeeder offers widgets that enable users to display their StyleFeed on various social networks and personal websites. The service includes social networking features, allowing users with similar tastes, referred to as StyleTwins, to connect and interact. Acquired by Time Inc. in 2010, StyleFeeder operates in a competitive landscape that includes other social shopping platforms.
Top10 Media
Venture Round in 2006
Top10 Media provides online networking services for publishing and retail applications. Its services allow users to tap into blogs, podcasts, video, and mainstream news outlets on the Web. The company also offers a set of algorithms that automatically categorize and rank user-generated and other Web-based content. Top10 Media, Inc. was founded in 2005 and is headquartered in Cambridge, Massachusetts.
Millstone Medical
Acquisition in 2004
Millstone provider of outsourced quality-critical services for medical manufacturers. The Company is strategically positioned to benefit from several strong secular trends, including increased demand for outsourced post-manufacturing services and significant growth in robotic-assisted surgery.
ExecuTrain
Acquisition in 1999
ExecuTrain is an educational services provider based in Georgia, founded in 1984 by Andy Atkins. The company specializes in a variety of training solutions aimed at corporate clients, including classroom training, virtual instructor-led training (VILT), e-learning support, and training room rentals. ExecuTrain also offers a comprehensive learning management system and services such as learning program management and custom development. Its course offerings encompass a wide range of topics, including Microsoft Office, technical skills, Cisco, VMware, information security, ITIL, Amazon Web Services, programming, Linux, Adobe, and business skills. Additionally, ExecuTrain provides instructional design and educational logistics to enhance the training experience for its clients.
Onebeat
Onebeat is a developer of AI-driven retail technology that focuses on optimizing inventory management and sales execution. The company's software provides real-time insights into customer behavior, allowing retailers to adjust their strategies daily based on market trends and demand fluctuations. By synchronizing store management and online sales, Onebeat enables retailers to effectively manage product inventory and tailor the variety of products offered at each sales point. This approach helps businesses react swiftly to customer preferences and adapt to ever-changing market dynamics, ultimately enhancing sell-through rates and overall sales performance.
Remedy Plan Therapeutics
Remedy Plan Therapeutics is a pre-clinical-stage biopharmaceutical company focused on developing small molecule therapeutics aimed at halting tumor growth and disrupting cancer stem cells, which are responsible for metastasis and chemotherapy resistance. The company employs a proprietary drug screening platform that identifies candidates capable of differentiating cancer stem cells and inhibiting tumor formation. In its initial screening, Remedy Plan evaluated 40,000 drug components, leading to the optimization of a lead candidate that is currently undergoing mechanism of action studies in preparation for Phase I clinical trials. Additionally, a second screening of over 100,000 drug components has been completed, positioning the company to potentially advance at least two drug candidates into clinical development. Through its innovative approach, Remedy Plan aims to address various cancers, including solid tumors and hematologic malignancies, while also exploring applications in obesity and autoimmune disorders.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.